Skip to main content
BP

BIOPOL PLA

This company focuses on producing second-generation base Polylactic Acid (PLA) onsite using tailored enzymes and microbial bacteria. They offer IP licensing packages that include tailored processes and patents for PLA production from lactic acid. Their PLA product is fully biodegradable, free of microplastics, and supports composting over traditional recycling.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Manufacturers of conventional plastics face increasing pressure to replace fossil‑based polymers with sustainable alternatives, yet existing polylactic acid (PLA) production relies on first‑generation feedstocks, generates microplastic residues, and often requires centralized facilities that limit on‑site manufacturing and circularity.

Solution

The company provides a bio‑resource platform that enables on‑site synthesis of second‑generation (2G) base PLA from tailored enzymatic cascades and engineered microbial strains. By converting lactide acid derived from renewable feedstocks directly into high‑purity polylactide, the process eliminates the need for large, off‑site plants and supports closed‑loop composting. The resulting polymer is fully biodegradable, leaves no microplastic trace, and can be integrated into existing extrusion or molding lines. To accelerate adoption, the firm offers comprehensive IP licensing packages that bundle custom enzyme formulations, microbial strain libraries, scale‑up protocols, and patented process designs. Licensees receive technical support and access to a cloud‑based analytics suite that monitors fermentation performance and polymer quality in real time.

Target Audience

Primary customers are plastics manufacturers, packaging producers, and consumer‑goods companies seeking to replace conventional plastics with fully compostable PLA, as well as R&D labs and biotech firms requiring licensed bioprocess technology for on‑site polymer production.

Features

  • Engineered microbial consortia optimized for high‑yield lactide conversion and low‑by‑product formation
  • Proprietary, tailor‑made enzyme cocktails that accelerate polymerization at reduced temperature and pressure
  • Modular, on‑site bioreactor design supporting scalable production from pilot to industrial capacity
  • Integrated process control software with real‑time analytics for fermentation monitoring and quality assurance
  • Full IP licensing bundles: custom process documentation, patents, and technology transfer services
  • Produced PLA meets compostability standards (e.g., EN 13432) and is free of detectable microplastics
  • Compatibility with standard downstream polymer processing equipment (extrusion, injection molding)
  • Sustainable feedstock flexibility, allowing use of second‑generation lactide sourced from agricultural residues
This profile is AI-generated and may contain inaccuracies.